Menquadfi Market Report 2026

Menquadfi Market Overview

• The Menquadfi market growth in the historic period has been driven by expansion of routine childhood immunization schedules, increased awareness of meningococcal disease risks • Market expansion is supported by increasing demand for booster vaccinations, expansion of travel and outbreak-related immunization • Growth Driver: Rising Meningitis Prevalence Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Menquadfi Market?

MenQuadfi is a quadrivalent meningococcal conjugate vaccine developed to protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. It uses tetanus toxoid as a protein carrier to enhance immune response and is approved for use in individuals aged two years and older. MenQuadfi is designed to provide broad, long-lasting protection and can be used for primary immunization or booster doses. Its unique formulation contributes to consistent immunogenicity across all four serogroups and age groups, addressing a critical need in the prevention of meningococcal disease globally. The main types vaccines of menquadfi are conjugate vaccines and combination vaccines. A conjugate vaccine is a type of vaccine that combines a weak antigen with a strong antigen to enhance the body's immune response. It is used for meningococcal disease prevention, outbreak control, travel vaccination, and routine immunization and is distributed through hospital pharmacies, retail pharmacies, online pharmacies, and public health departments (government). It is used for infants and young children, adolescents, adults, and older adults by hospitals, specialty clinics, vaccination centers, academic and research institutions, and homecare settings.

What Is The Menquadfi Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for booster vaccinations, expansion of travel and outbreak-related immunization, growing investments in next-generation vaccine platforms, rising focus on global disease prevention, increased adoption of life-course immunization strategies. Major trends in the forecast period include increasing adoption of quadrivalent conjugate vaccines, rising focus on long-term immunogenicity, growing demand for broad-spectrum meningococcal protection, expansion of global immunization programs, enhanced emphasis on vaccine safety and consistency.

Global Menquadfi Market Segmentation

1) By Type Of Vaccine: Conjugate Vaccine, Combination Vaccine 2) By Indication: Meningococcal Disease Prevention, Outbreak Control, Travel Vaccination, Routine Immunization 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Public Health Departments (Government) 4) By Age Group: Adolescents, Adults, Older Adults 5) By End User: Hospitals, Specialty Clinics, Vaccination Centers

What Are The Drivers Of The Menquadfi Market?

The increasing prevalence of meningitis is expected to propel the growth of the menquadfi market going forward. Meningitis is an inflammation of the protective membranes (meninges) surrounding the brain and spinal cord, often caused by infections from bacteria, viruses, or fungi, and can lead to serious complications if untreated. The prevalence of meningitis is rising due to factors such as increased global travel, higher rates of bacterial infections, and growing numbers of immunocompromised individuals. MenQuadfi is required for meningitis as it provides protection against neisseria meningitidis, the bacteria responsible for causing invasive meningococcal meningitis, a potentially life-threatening infection of the brain and spinal cord. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, 143 cases of meningococcal disease were reported in the United States as of March 25, marking an increase compared to 81 cases during the same period last year. Therefore, the increasing prevalence of meningitis is driving the growth of the menquadfi industry. The increase in global travel is expected to propel the growth of the menquadfi market going forward. Global travel is rising due to factors such as increased economic growth, greater accessibility to affordable transportation, and a growing desire for cultural exchange and tourism. Menquadfi, a meningococcal vaccine, is often required for international travel to countries with a high risk of meningitis, particularly in sub-Saharan Africa, to prevent the spread of the disease. For instance, in February 2024, according to the United Nations World Tourism Organization, a US-based specialized agency of the United Nations, reported that international tourism ended 2023 at 88% of pre-pandemic levels, with an estimated 1.3 billion international arrivals. Therefore, the increase in global travel is driving the growth of the menquadfi industry. The growing healthcare infrastructure is expected to propel the growth of the menquadfi market going forward. Healthcare infrastructure refers to the physical facilities, equipment, personnel, and systems necessary to deliver healthcare services, including hospitals, clinics, laboratories, and supporting technologies. Healthcare infrastructure is growing due to increasing population demands, advancements in medical technology, rising health awareness, and greater government and private sector investments in improving healthcare accessibility and quality. The growth of healthcare infrastructure enhances the accessibility and distribution of vaccines such as MenQuadfi, ensuring that more individuals in diverse regions can receive protection against meningococcal disease. Improved facilities and resources also support effective vaccination campaigns, public awareness, and storage capabilities, boosting overall demand for the vaccine. For instance, in May 2023, according to the American Hospital Association, a US-based national organization, the United States had 6,129 hospitals in 2023, reflecting a 0.591% increase from the 6,093 hospitals recorded the previous year. Therefore, the growing healthcare infrastructure is driving the growth of the menquadfi industry.

Key Players In The Global Menquadfi Market

Major companies operating in the menquadfi market are Sanofi S.A.

Regional Insights

North America was the largest region in the menquadfi market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Menquadfi Market?

The menquadfi market consists of sales of meningococcal vaccines, pneumococcal vaccines, influenza vaccines, and hepatitis vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Menquadfi Market Report 2026?

The menquadfi market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the menquadfi industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.